InvestorsHub Logo
Followers 155
Posts 2641
Boards Moderated 0
Alias Born 01/29/2004

Re: ExtremelyBullishZig post# 391611

Sunday, 12/11/2022 10:01:52 PM

Sunday, December 11, 2022 10:01:52 PM

Post# of 462089
It is the best.

But, you were so sure this drug [blarcamesine] was the absolute best because of murine models...what happened?


Well, I'm still sure of that. Blarcamesine beats any of the existing drugs approved to treat Alzheimer's. Do any of the monoclonal antibodies targeting tau or amyloid plaques match or exceed blarcamesine's now clinically demonstrated abilities to stop or reverse the progression of Alzheimer's? Does the acetylcholinesterase-inhibitor Aricept do that? Nope.

Right now, blarcamesine, if available, would be the best Alzheimer's therapeutic.

If you'd like, please make the case for either the monoclonal antibodies or Aricept over blarcamesine.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News